TRANSFORMED LYMPHOMA
Clinical trials for TRANSFORMED LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-phase trial is testing a treatment where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells. It is for people with certain types of Non-Hodgkin lymphoma that have come back or not responded to standard treatments. The main go…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1 • Sponsor: C. Babis Andreadis • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to stop High-Risk lymphoma relapse after cell treatment
Disease control Recruiting nowThis study tests whether the drug acalabrutinib, taken as a pill, can safely prevent relapse in people with very high-risk large B-cell lymphoma after they receive cell therapy (stem cell transplant or CAR T-cells). The trial will enroll 24 adults aged 18-70. Researchers will tra…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC